|
70
|
243
|
4qvmF |
Ycp beta5-m45a mutant in complex with bortezomib |
|
63
|
241
|
4r18G |
Ligand-induced lys33-thr1 crosslinking at subunit beta5 of the yeast 20s proteasome |
|
67
|
240
|
4qwfC |
Ycp beta5-m45i mutant in complex with carfilzomib |
|
65
|
240
|
4r18C |
Ligand-induced lys33-thr1 crosslinking at subunit beta5 of the yeast 20s proteasome |
|
64
|
231
|
4qz3E |
Ycp beta5-a49v mutant in complex with the epoxyketone inhibitor onx 0914 |
|
59
|
222
|
4qwlH |
Ycp beta5-a50v mutant in complex with carfilzomib |
|
61
|
231
|
4qvpE |
Ycp beta5-m45t mutant in complex with bortezomib |
|
67
|
233
|
4qv3M |
Ycp beta5-m45v mutant |
|
63
|
241
|
4qw4G |
Ycp in complex with carfilzomib |
|
69
|
212
|
4qv7K |
Ycp beta5-a50v mutant |
|
63
|
241
|
4qv7G |
Ycp beta5-a50v mutant |
|
57
|
222
|
4qwkL |
Ycp beta5-a49t-a50v-double mutant in complex with carfilzomib |
|
71
|
243
|
4qwfF |
Ycp beta5-m45i mutant in complex with carfilzomib |
|
61
|
195
|
4qv8J |
Ycp beta5-c52f mutant |
|
70
|
212
|
4qlsK |
Ycp in complex with tripeptidic epoxyketone inhibitor 11 |
|
62
|
195
|
4r00J |
Ycp beta5-c52f mutant in complex with omuralide |
|
72
|
240
|
4qw1C |
Ycp beta5-a50v mutant in complex with bortezomib |
|
57
|
204
|
4quyI |
Ycp beta5-a49s-mutant |
|
68
|
249
|
4r17A |
Ligand-induced aziridine-formation at subunit beta5 of the yeast 20s proteasome |
|
62
|
195
|
4qwkJ |
Ycp beta5-a49t-a50v-double mutant in complex with carfilzomib |
|
59
|
196
|
4qz5N |
Ycp beta5-a49t-mutant in complex with onx 0914 |
|
70
|
242
|
4qv6D |
Ycp beta5-a49v mutant |
|
57
|
204
|
4qz6I |
Ycp beta5-a49t-a50v double mutant in complex with the epoxyketone inhibitor onx 0914 |
|
64
|
250
|
4qw3A |
Ycp beta5-c63f mutant in complex with bortezomib |
|
57
|
204
|
4qv9I |
Ycp beta5-c63f mutant |
|
68
|
244
|
4qwxB |
Ycp in complex with the epoxyketone inhibitor onx 0914 |
|
61
|
222
|
4qltL |
Ycp in complex with tripeptidic epoxyketone inhibitor 2 (pr924) |
|
69
|
240
|
4qxjC |
Ycp beta5-m45a mutant in complex with the epoxyketone inhibitor onx 0914 |
|
71
|
243
|
4qz3F |
Ycp beta5-a49v mutant in complex with the epoxyketone inhibitor onx 0914 |
|
69
|
233
|
4qvlM |
Ycp in complex with bortezomib |
|
59
|
226
|
4qw3H |
Ycp beta5-c63f mutant in complex with bortezomib |
|
70
|
212
|
4qw5K |
Ycp beta5-m45a mutant in complex with carfilzomib |
|
58
|
226
|
4qv9H |
Ycp beta5-c63f mutant |
|
73
|
243
|
4qlqF |
Ycp in complex with tripeptidic epoxyketone inhibitor 8 |
|
66
|
233
|
4qzwM |
Ycp beta5-c52f mutant in complex with the epoxyketone inhibitor onx 0914 |
|
61
|
196
|
4qvpN |
Ycp beta5-m45t mutant in complex with bortezomib |
|
63
|
195
|
4qltJ |
Ycp in complex with tripeptidic epoxyketone inhibitor 2 (pr924) |
|
64
|
231
|
4qv7E |
Ycp beta5-a50v mutant |
|
71
|
250
|
4qv0A |
Ycp beta5-a49t-a50v-double mutant |
|
62
|
241
|
4qv4G |
Ycp beta5-m45t mutant |
|
59
|
226
|
4qwuH |
Ycp beta5-c52f mutant in complex with bortezomib |
|
67
|
212
|
4qvwK |
Ycp beta5-a49s-mutant in complex with bortezomib |
|
62
|
231
|
4qvvE |
Ycp beta5-a49v mutant in complex with bortezomib |
|
64
|
195
|
4qlqJ |
Ycp in complex with tripeptidic epoxyketone inhibitor 8 |
|
70
|
242
|
4qzzD |
Ycp in complex with omuralide |
|
57
|
204
|
4qvnI |
Ycp beta5-m45v mutant in complex with bortezomib |
|
68
|
233
|
4quxM |
Ycp beta5-a49t-mutant |
|
59
|
222
|
4qz0L |
Ycp beta5-m45v mutant in complex with the epoxyketone inhibitor onx 0914 |
|
60
|
196
|
4qz4N |
Ycp beta5-a49s mutant in complex with the epoxyketone inhibitor onx 0914 |
|
70
|
242
|
4qvvD |
Ycp beta5-a49v mutant in complex with bortezomib |
